Bacterial Meningitis (Opus)

Acute bacterial meningitis is a purulent, pyogenic infection of the leptomeninges and the cerebrospinal-fluid-filled subarachnoid space, clinically defined by an acute meningitic syndrome accompanied by a neutrophil-predominant CSF pleocytosis and a bacterial pathogen identified in CSF; in adults the dominant causative organisms are Streptococcus pneumoniae and Neisseria meningitidis , with Listeria monocytogenes , Haemophilus influenzae , and Staphylococcus aureus as important less-common causes ^{[1]A1b[2]A1b[12]B2b}.

According to PubMed, in the Dutch nationwide cohort of 696 culture-confirmed adult episodes, S. pneumoniae caused 51% and N. meningitidis 37% of cases (DOI) ^[1]A1b, and in the later 2006-2014 cohort of 1412 episodes pneumococcus rose to 72% as meningococcal disease fell after vaccine introduction (DOI) ^[2]A1b.

Causative organisms (REQUIRED)

Classification

Sibling syndromes include viral meningitis , encephalitis , and brain abscess , which overlap clinically but diverge sharply in CSF profile and therapy. The community-versus-healthcare distinction is more than academic: in the Dutch cohorts the community-acquired spectrum is dominated by pneumococcus and meningococcus, whereas post-neurosurgical and post-traumatic disease is dominated by staphylococci and aerobic Gram-negative bacilli such as Klebsiella, Enterobacter and E. coli, and in one neurosurgical series cephalosporin susceptibility actually fell during cephalosporin treatment, mandating MIC-guided therapy and often a carbapenem ^[18]D5. Host immune status further refines the differential: complement deficiency and asplenia predispose to encapsulated organisms including meningococcus, alcoholism and age over 50 to Listeria and pneumococcus, and underlying colonic neoplasia to Streptococcus gallolyticus, whose isolation should trigger colonoscopy and echocardiography ^[17]C4. Recognizing the syndrome as community-acquired, in an immunocompetent versus immunocompromised host, with or without a parameningeal source, is therefore the organizing framework that determines the empiric regimen before any culture result returns ^{[9]B2b[11]B2b[18]D5}. Pearl: The single classification decision that most changes empiric therapy is whether a Listeria monocytogenes risk factor (age >50, pregnancy, impaired cell-mediated immunity) is present, because third-generation cephalosporins do not cover Listeria and ampicillin must be added ^[18]D5[20]C4.

Understanding the organism lets the reader derive both the syndrome and the diagnostic tests. Streptococcus pneumoniae is a Gram-positive, lancet-shaped diplococcus that is alpha-hemolytic, optochin-sensitive, bile-soluble, and polysaccharide-encapsulated; the capsule is the principal antiphagocytic virulence determinant and the basis of serotyping and conjugate vaccines (see Gram stain). Neisseria meningitidis is a Gram-negative, oxidase-positive diplococcus that grows on chocolate agar and carries an endotoxic lipooligosaccharide, while Listeria monocytogenes is a Gram-positive, facultatively intracellular, tumbling-motile bacillus whose CSF Gram stain is notoriously variable and easily missed. According to PubMed, pneumococcus is increasingly recognized as a facultatively intracellular pathogen that uses pneumolysin, PspA, PavB, the pilus adhesin RrgA, pyruvate oxidase (SpxB) and a metalloprotease to invade and persist, including translocation across the blood-brain barrier (DOI) ^[13]D5. Experimental work shows pneumolysin upregulates CREB-binding protein and tumor necrosis factor alpha, increasing blood-brain barrier permeability and promoting meningeal invasion (DOI) ^[15]D5, and that the same choline-binding protein A and phosphorylcholine interactions that mediate cardiac invasion also drive translocation into the central nervous system (DOI) ^[14]D5.

Virulence factor -> clinical effect (REQUIRED)

Pathogenesis cascade

1. Acquisition and nasopharyngeal colonization (or contiguous spread from otitis/sinusitis, or hematogenous seeding from a distant focus such as endocarditis) ^{[9]B2b[11]B2b}.
2. Mucosal invasion and bacteremia, with capsule-mediated immune evasion sustaining high-grade bloodstream survival ^[13]D5.
3. Adhesion to and translocation across the blood-brain barrier via CbpA-laminin-receptor and phosphorylcholine-PAFr interactions ^[13]D5[14]D5.
4. Replication in the relatively immune-privileged subarachnoid space with release of pneumolysin and shed cell-wall fragments ^[13]D5[15]D5.
5. Massive innate immune activation (TLR signaling, TNF-alpha, IL-1, complement) producing a brisk neutrophilic CSF pleocytosis ^[13]D5.
6. Cerebral edema , raised intracranial pressure , vasculitis and impaired cerebral autoregulation cause ischemia ^[13]D5[14]D5.
7. The combined inflammatory and ischemic injury yields the cardinal clinical syndrome and its complications, from depressed consciousness to hearing loss ^[13]D5[15]D5.

From this cascade the reader can predict every diagnostic finding: the neutrophilic pleocytosis reflects the innate immune influx, the low CSF glucose reflects accelerated glycolysis by leukocytes and bacteria, the high CSF protein reflects barrier breakdown, and the elevated CSF lactate reflects anaerobic metabolism in the inflamed space - which is why CSF lactate discriminates bacterial from viral disease so well ^{[13]D5[19]B2b}. The microbiology also explains epidemiology: capsular serotypes that evade immunity are the ones targeted by conjugate vaccines, so vaccination reshapes which organisms reach the meninges ^[21]B2b. The intracellular survival strategy of pneumococcus, hiding in vacuoles and modulating virulence-gene expression, additionally helps explain antibiotic tolerance and the occasional persistence despite susceptible MICs ^[13]D5.

Pearl: The mechanistic fact that explains the cardinal features is that the inflammatory response itself, not just the bacterium, drives BBB breakdown and cerebral edema, which is precisely why adjunctive anti-inflammatory dexamethasone given with the first antibiotic improves outcome by blunting the cytokine surge unleashed when antibiotics lyse bacteria ^[3]A1b[13]D5.

According to PubMed, adult community-acquired bacterial meningitis incidence in the Netherlands fell from 1.72 to 0.94 cases per 100,000 adults per year between 2007-08 and 2013-14, attributable partly to herd protection from pediatric conjugate vaccines, with S. pneumoniae causing 72% of 1412 episodes (DOI) ^[2]A1b. Predisposing foci such as otitis or sinusitis are common: otitis was present in 27% of 2548 episodes and was associated with a more favorable outcome (DOI) ^[11]B2b, and recurrent meningitis (~6% of episodes) clusters in patients with CSF leak and ENT infection (DOI) ^[9]B2b. Incubation for meningococcal disease is typically short (commonly cited as up to ~10 days and usually under 4) though precise incubation was not quantified in these cohorts.

Transmission and risk (REQUIRED)

Host factors compound exposure: immunocompromising conditions were present in 25% of adult H. influenzae cases, and CSF leak or ENT infection in roughly half ^[12]B2b. The epidemiologic signature is therefore a shift from young, previously healthy meningococcal patients toward older patients with comorbidities and parameningeal foci. This demographic transition has direct therapeutic consequences: an older cohort means a higher background prevalence of Listeria risk factors, reinforcing the empiric addition of ampicillin in patients over 50 ^[18]D5[20]C4. The recurrent-meningitis literature sharpens the point - in 143 recurrent episodes among 123 patients, predisposing factors were identified in 74%, dominated by ear or sinus infection (36%) and CSF leakage (32%), with pneumococcus (65%) and H. influenzae (13%) the leading pathogens ^[9]B2b. Transmission for the encapsulated respiratory pathogens is by respiratory droplets and requires only close, prolonged contact, which is why household and intimate contacts of meningococcal cases warrant chemoprophylaxis, whereas Listeria is acquired from contaminated food and S. aureus seeds the meninges hematogenously from endocarditis or spondylodiscitis rather than spreading person-to-person ^{[2]A1b[10]B2b[20]C4}. Pearl: The exposure most worth eliciting is a parameningeal focus or CSF leak - otitis, sinusitis, recent head trauma or persistent rhinorrhea - because it changes both source control and the likelihood of recurrence ^{[9]B2b[11]B2b}.

Bacterial meningitis presents as an acute, rapidly progressive illness that follows the pathogenesis: after colonization and bacteremia, meningeal inflammation produces headache and meningismus , the cytokine-driven systemic response produces fever and tachycardia, and rising intracranial pressure with cerebral involvement produces depressed consciousness, seizures and focal deficits. According to PubMed, in 696 adults the classic triad of fever, neck stiffness and altered mental status was present in only 44% of episodes, yet 95% had at least two of the four cardinal features (headache, fever, neck stiffness, altered mental status); 14% were comatose and 33% had focal neurologic abnormalities on admission (DOI) ^[1]A1b. A petechial or purpuric rash suggests meningococcemia and may herald disseminated intravascular coagulation. In Staphylococcus aureus meningitis the triad was present in only 17%, reflecting its hematogenous, endocarditis-associated nature (DOI) ^[10]B2b. The timeline runs from a short prodrome of upper-respiratory or otitic symptoms to overt meningitis over hours to a few days; abrupt fulminant presentations occur with meningococcus, sometimes progressing from well-being to shock within hours. Because the mechanism is meningeal and cerebral inflammation, the patient typically appears systemically unwell - prostrate, photophobic, and irritable - in contrast to the better-appearing patient with viral meningitis . Older and immunocompromised patients may present atypically, with confusion or coma dominating and neck stiffness blunted, so a high index of suspicion is essential. Seizures, cranial-nerve palsies (notably the abducens and facial nerves) and papilledema signal raised intracranial pressure or focal cerebritis and should prompt consideration of CT before lumbar puncture ^{[1]A1b[12]B2b}. The presence of a parameningeal focus such as otitis or sinusitis on examination both supports the diagnosis and points to the likely pathogen and source-control need ^[11]B2b.

Signs and discriminating value (REQUIRED)

Pearl: The feature that most shifts pretest probability is the combination - absence of all of fever, neck stiffness, AND altered mental status makes bacterial meningitis unlikely, but reliance on the full classic triad will miss most cases because its sensitivity is only ~44%; eponymous Kernig sign and Brudzinski sign are too insensitive to exclude disease ^[1]A1b[18]D5.

Diagnosis rests on cerebrospinal fluid examination after lumbar puncture , supported by blood cultures and, when indicated, neuroimaging. For each test, the expected finding in pyogenic meningitis is a neutrophilic CSF picture with high protein, low glucose and a positive microbiology.

Diagnostic tests - findings and performance (REQUIRED)

TEST OF CHOICE: Lumbar puncture with CSF analysis is the first-line, most useful practical test - it yields cell count, chemistry, Gram stain, culture, lactate and PCR from a single sample, and prompt LP is associated with better outcomes ^{[1]A1b[7]B2b[18]D5}.

GOLD STANDARD: CSF culture (with concurrent blood cultures) is the reference standard against which all other tests are measured, because it confirms the organism and provides susceptibilities ^[1]A1b[18]D5.

Diagnostic algorithm (REQUIRED)

The Swedish and Dutch cohorts show prompt LP without mandatory prior imaging is associated with lower mortality, and that impaired mental status or immunosuppression alone should not trigger imaging first ^[7]B2b[8]B2b.

Differential diagnosis

Pearl: The single result that rules in fastest is a positive CSF Gram stain or markedly elevated CSF lactate (>7.2 mmol/L, ~93% sensitive/100% specific in one series), while a bland lymphocytic CSF with normal lactate rules bacterial meningitis out fastest ^{[18]D5[19]B2b}.

Severity is driven by the depth of consciousness, systemic compromise, and the causative organism. According to PubMed, in 696 adults the strongest independent predictors of unfavorable outcome were advanced age, low admission Glasgow Coma Scale, tachycardia, positive blood culture, a low CSF white-cell count, and pneumococcal etiology (DOI) ^[1]A1b; the 1412-episode cohort added alcoholism, cranial nerve palsy, and high CRP ^[2]A1b. A systematic review and external validation of nine meningitis risk scores found that, although some discriminated reasonably in meningococcal disease (AUC up to 0.90), none performed well enough to guide individual management, with bacterial-meningitis AUCs of only 0.59-0.74 (DOI) ^[16]B2a.

Severity / risk tools (REQUIRED)

Because no single score reliably individualizes prognosis, clinicians integrate the GCS trajectory, hemodynamics, and microbiologic data at the bedside rather than relying on a calculated number ^[16]B2a. The external-validation study is instructive: of nine published scores, discrimination ranged from an AUC of only 0.59 in some bacterial-meningitis applications to 0.90 in selected meningococcal cohorts, but statistical testing indicated poor calibration for all of them, meaning predicted and observed risks diverged enough that none could be safely used to make individual treatment or triage decisions ^[16]B2a. The authors recommended only one score for the interpretation and design of meningitis studies rather than for patient care. In practice, the variables that populate these scores - age, depressed GCS, tachycardia, positive blood culture, low CSF white-cell count (a marker of overwhelming infection with a blunted host response), and pneumococcal etiology - remain the most useful bedside red flags, and their co-occurrence should lower the threshold for ICU admission, invasive monitoring, and early infectious-diseases and neurology input ^{[1]A1b[2]A1b[16]B2a}. Pearl: The threshold at which care escalates is a depressed or falling Glasgow Coma Scale (especially coma) together with hemodynamic instability or a positive blood culture - these patients need ICU-level monitoring even though a single validated score cannot reliably individualize prognosis ^{[1]A1b[16]B2a}.

Empiric management is a time-critical sequence: recognize, draw blood cultures, give adjunctive dexamethasone with or just before the first antibiotic, and start broad empiric antibiotics without waiting for LP or CT when imaging is indicated.

Empiric pathway (REQUIRED)

Evidence-graded explanation

The ANTIBIOTIC OF CHOICE for empiric therapy in an immunocompetent adult is ceftriaxone (2 g IV every 12 hours) plus vancomycin (to cover penicillin/cephalosporin-resistant pneumococcus), adding ampicillin (2 g IV every 4 hours) when Listeria monocytogenes risk is present (age >50, pregnancy, alcoholism, impaired cell-mediated immunity) (1b; IDSA strong) ^{[1]A1b[18]D5[20]C4}. In healthcare-associated or post-neurosurgical disease, substitute an antipseudomonal beta-lactam such as meropenem or cefepime with vancomycin , because Gram-negative bacilli and staphylococci predominate and susceptibility may shift on therapy (4; conditional) ^[18]D5.

Adjunctive dexamethasone 0.15 mg/kg (10 mg) IV every 6 hours for 4 days, given with or before the first antibiotic dose, reduced unfavorable outcome (RR 0.59, 95% CI 0.37-0.94) and death (RR 0.48, 95% CI 0.24-0.96) in the European RCT, with the largest benefit in pneumococcal meningitis (1b; strong) (DOI) ^[3]A1b; the Cochrane review confirmed reduced mortality and hearing loss in high-income adults (1a) ^[4]A1a. With ~26% versus 52% unfavorable outcome in pneumococcal disease, the absolute risk reduction is ~26%, giving an approximate NNT of ~4 in that subgroup; the broader individual-patient meta-analysis was neutral overall, so benefit is concentrated in high-income, pneumococcal, early-treated patients - in other groups the benefit is not derivable from the reported data ^[3]A1b[5]A1a.

Source control - drainage of mastoiditis /sinusitis, repair of CSF leak , or management of endocarditis - and supportive ICU care for raised intracranial pressure and seizures are essential adjuncts ^{[10]B2b[11]B2b}. In the nationwide otitis analysis an ENT specialist was consulted in 82% of otogenic cases and surgery (myringotomy, ventilation tube, or mastoidectomy) performed in 55%, although surgery itself was not shown to change outcome, underscoring that prompt antibiotics and dexamethasone, not the operation, drive recovery ^[11]B2b. The practical acute bundle therefore is: secure airway and circulation, draw blood cultures, give dexamethasone, give the empiric regimen within the door-to-needle window, perform LP as soon as it is safe, and admit to a monitored or ICU bed with neurologic observation ^[7]B2b[18]D5.

Key supportive measures include managing intracranial pressure (head-of-bed elevation, osmotherapy, and neurosurgical CSF diversion for hydrocephalus), controlling seizures with antiepileptics, correcting hyponatremia, and maintaining cerebral perfusion. Repeat lumbar puncture is not routinely required if the patient improves on an appropriate regimen but should be considered when there is no clinical response by 48 hours or when a resistant pneumococcus is treated with vancomycin plus a cephalosporin ^[18]D5.

Pearl: The time-sensitive action that most changes outcome is shortening door-to-antibiotic time; prompt LP-then-antibiotics (not imaging-first) was associated with lower mortality (aOR 0.38) and better outcome (aOR 2.11) ^[7]B2b.

Once the organism and susceptibilities return, therapy is narrowed (de-escalated) to the most active, narrowest-spectrum agent for the documented duration. Vancomycin is dropped once a penicillin- or cephalosporin-susceptible pneumococcus is confirmed, and ampicillin is continued only if Listeria monocytogenes is grown. Susceptibility-guided definitive therapy both improves cure rates and limits selection pressure.

Organism-directed therapy (REQUIRED)

The Gram-negative post-neurosurgical series found no failures when appropriate therapy continued for more than 12 days, and treatment for at least 14 days after the last positive CSF culture reliably achieved cure; importantly, two patients on cephalosporins developed decreasing susceptibility on therapy, illustrating why MIC-driven de-escalation matters ^[18]D5. Because adequate CNS penetration must be maintained, IV therapy is generally continued for the full course; routine early IV-to-oral switch is not standard in bacterial meningitis, unlike many other infections, and de-escalation is achieved by narrowing spectrum rather than changing route. NNT/NNH for shorter-versus-longer durations are not derivable from the reported data.

Duration is anchored to the organism rather than to clinical resolution alone: meningococcal disease is reliably cured in 7 days, pneumococcal disease in 10-14 days, Listeria monocytogenes requires at least 21 days because of its intracellular niche and the bactericidal limits of ampicillin, and Gram-negative neurosurgical meningitis is treated for 21 days or more and at least 14 days beyond the last sterile CSF culture ^{[1]A1b[18]D5[20]C4}. The adjunctive gentamicin sometimes added for Listeria is for synergy and is typically limited in duration to mitigate nephro- and ototoxicity. When a contiguous or hematogenous focus exists - endocarditis or spondylodiscitis in Staphylococcus aureus disease - the duration is governed by that deeper infection and is correspondingly longer, with source control as an inseparable part of cure ^[10]B2b. Throughout, de-escalation means converting a broad empiric regimen (ceftriaxone + vancomycin +/- ampicillin) to the single narrowest active agent the moment susceptibilities allow, which both protects the patient from unnecessary drug toxicity and reduces ecological selection pressure ^[18]D5.

Pearl: The de-escalation decision most often gotten wrong is failing to stop vancomycin and ampicillin once a fully susceptible pneumococcus or meningococcus is confirmed - and conversely stopping ampicillin too early in confirmed Listeria monocytogenes , which needs at least 21 days of therapy ^[18]D5[20]C4.

Resistance is clinically meaningful chiefly for Streptococcus pneumoniae , where penicillin and cephalosporin non-susceptibility drives the empiric addition of vancomycin ; meningococcal penicillin resistance and Listeria beta-lactam resistance are comparatively uncommon but evolving. According to PubMed, pneumococcus is a WHO priority pathogen for new antibacterials owing to acquired resistance and non-vaccine serotype emergence (DOI) ^[13]D5, and conjugate vaccination reduced penicillin-resistant strains as vaccine serotypes disappeared, although serotype replacement tempered the population-level effect (DOI) ^[21]B2b. Whole-genome work in Listeria meningitis has linked a plasmid-borne efflux gene (emrC) to worse-outcome ST6 clones with higher amoxicillin and gentamicin MICs, a reminder that resistance can co-segregate with virulence (DOI) ^[20]C4.

Resistance mechanisms (REQUIRED)

Stewardship

• De-escalate promptly to the narrowest effective agent once susceptibilities return (stop empiric vancomycin / ampicillin when not needed) ^[18]D5.
• Use the shortest guideline-supported duration for the organism (e.g. 7 days for meningococcus) ^[1]A1b[18]D5.
• Avoid unnecessary broad-spectrum continuation; reserve carbapenems for documented resistant Gram-negatives ^[18]D5.
• Support vaccination programs, which lower resistant-strain prevalence at the population level ^[21]B2b.
• Obtain MICs (not just qualitative susceptibility) for pneumococcus so cephalosporin breakpoints for CNS infection are correctly applied, because a strain susceptible for pneumonia may be non-susceptible for meningitis ^[13]D5[18]D5.

It is worth stating plainly that, for the two commonest adult pathogens, classical resistance is still the exception rather than the rule: most meningococci remain penicillin-susceptible and most pneumococci remain ceftriaxone-treatable, so the empiric vancomycin is a hedge against the resistant minority and should be a short-lived component of therapy. Where resistance genuinely reshapes care is in the post-neurosurgical Gram-negative population and in MRSA disease, where molecular and phenotypic testing must drive carbapenem or vancomycin selection and where infection-control measures to prevent device-associated transmission matter as much as the antibiotic choice ^{[10]B2b[18]D5}.

Pearl: The stewardship step with the biggest resistance-prevention payoff is timely de-escalation off vancomycin and broad agents the moment a susceptible pathogen is confirmed, reinforced by conjugate vaccination that shrinks the resistant-pneumococcus reservoir ^{[18]D5[21]B2b}.

Complications arise both from the meningeal/cerebral disease itself and from its therapy. Disease complications stem from inflammation, raised intracranial pressure, vasculitis and dissemination; therapy complications include drug toxicity and healthcare-associated infection. In the large adult cohorts, neurologic complications are common - focal deficits in roughly a third and coma in one in seven at admission - and they drive the high rate of unfavorable outcome ^[1]A1b. Systemic complications track with the bacteremic, septic phenotype: tachycardia, a positive blood culture, and a high CRP all predict poor outcome and reflect the severity of the systemic inflammatory response ^[1]A1b[2]A1b. The complications below should be actively screened for, because several (raised ICP, seizures, hyponatremia, hearing loss) are reversible or preventable with timely recognition. It is useful to separate complications by timing as well as origin. Early disease complications - cerebral edema, seizures, septic shock and disseminated intravascular coagulation - occur within hours to days and dominate acute mortality, particularly in pneumococcal and meningococcal disease ^[1]A1b[2]A1b. Intermediate complications such as cerebrovascular infarction from inflammatory arteritis, hydrocephalus, and ventriculitis evolve over the first one to two weeks. Late and chronic sequelae - sensorineural hearing loss and neuropsychological impairment - are the principal long-term burdens among survivors, with pneumococcal survivors at significantly higher risk of cognitive dysfunction than meningococcal survivors ^[6]A1b. Therapy-associated harms run in parallel: prolonged broad-spectrum antibiotics predispose to Clostridioides difficile infection, vancomycin and aminoglycosides carry nephro- and ototoxicity, and indwelling devices in neurosurgical patients invite secondary nosocomial infection - each a reason to de-escalate and shorten therapy as soon as microbiology permits ^[18]D5.

Complications (REQUIRED)

Pearl: The most preventable complication with correct early management is severe sensorineural hearing loss , which adjunctive dexamethasone given with the first antibiotic significantly reduces, alongside the broader benefit of minimizing door-to-antibiotic delay ^[4]A1a[5]A1a.

Untreated, acute bacterial meningitis is almost uniformly fatal; even with optimal modern therapy it remains a high-mortality disease. According to PubMed, overall in-hospital mortality was 21% in 696 adults and unfavorable outcome occurred in 34% (DOI) ^[1]A1b; in the larger 1412-episode cohort case fatality was 17% with unfavorable outcome in 38% (DOI) ^[2]A1b. Mortality is strongly organism-dependent - ~30% for pneumococcal versus ~7% for meningococcal meningitis ^[1]A1b - and reaches ~35% in community-acquired Staphylococcus aureus meningitis ^[10]B2b. The strongest predictors of poor outcome are advanced age, low admission Glasgow Coma Scale , tachycardia, positive blood culture, low CSF white-cell count, and pneumococcal etiology ^[1]A1b[2]A1b. Survivors of pneumococcal meningitis remain at significant risk for long-term cognitive dysfunction even years later ^[6]A1b. Recurrent meningitis, by contrast, carries a less severe course and lower case fatality (4% vs 17%) because predisposing CSF-leak/ENT cases are recognized and treated earlier ^[9]B2b. The natural history without treatment is rapid: subarachnoid bacterial proliferation, escalating intracranial pressure, cerebral edema and vascular compromise progress over hours, so the window in which intervention alters the trajectory is narrow. Even among survivors, morbidity is substantial - long-term cognitive impairment is significantly more common after pneumococcal than meningococcal meningitis, and sensorineural hearing loss is a frequent permanent sequela ^[6]A1b. Prognosis is therefore best framed as a race against time: the same factors that mark systemic and neurologic compromise on admission (low GCS, tachycardia, positive blood culture, low CSF white-cell count, advanced age, pneumococcal etiology) are largely fixed by the time the patient arrives, leaving speed of effective treatment and adjunctive dexamethasone as the principal levers a clinician can still pull ^{[1]A1b[2]A1b[3]A1b}. The organism remains the single most powerful prognostic axis: pneumococcal meningitis combines the highest mortality with the greatest risk of cognitive and audiologic sequelae, meningococcal meningitis is comparatively survivable when shock is averted, H. influenzae and non-typeable strains generally do well, and S. aureus meningitis is uniformly severe because of its endocarditis and spondylodiscitis associations ^{[1]A1b[10]B2b[12]B2b}. Outcome assessment in these cohorts uses the Glasgow Outcome Scale, where a score of 5 denotes favorable recovery and 1-4 unfavorable outcomes ranging from disability to death; tracking this scale at discharge and at 2-6 months captures both the acute survival question and the substantial late morbidity that defines the disease's true burden ^{[1]A1b[2]A1b[6]A1b}. For the survivor, structured neurologic, audiologic and neuropsychological follow-up is therefore part of good care rather than an optional extra ^[6]A1b.

Pearl: The single modifiable factor that most improves outcome is time to effective therapy - prompt antibiotics with adjunctive dexamethasone and avoidance of imaging-related delay, since prompt LP-then-treatment was associated with markedly lower mortality (aOR 0.38) ^[3]A1b[7]B2b.

Prevention combines vaccination, chemoprophylaxis of close contacts, and droplet precautions, with key modifications in special hosts. According to PubMed, pediatric pneumococcal conjugate vaccination produced herd protection that roughly halved adult meningitis incidence and reduced penicillin-resistant strains, although serotype replacement limited the net effect (DOI) ^{[21]B2b[2]A1b}.

Prevention and infection control (REQUIRED)

Special populations

• Age >50, pregnancy, alcoholism, and impaired cell-mediated immunity: add ampicillin for Listeria monocytogenes ; cephalosporins are inadequate ^[18]D5[20]C4.
• Pregnancy: heightened Listeria risk; ampicillin preferred, trimethoprim-sulfamethoxazole used if penicillin-allergic (with usual third-trimester cautions).
• Pediatrics/neonates: neonatal pathogens include group B Streptococcus, E. coli and Listeria (ampicillin + cefotaxime); dexamethasone benefit is clearest for childhood Hib in high-income settings ^[4]A1a[5]A1a.
• Renal/hepatic dosing: adjust vancomycin and beta-lactams for renal function; monitor vancomycin levels and aminoglycoside toxicity.
• Post-neurosurgical/CSF-shunt hosts: cover staphylococci and Gram-negative bacilli ( vancomycin + antipseudomonal beta-lactam) ^[18]D5.
• Asplenic and complement-deficient patients: prioritize pneumococcal, meningococcal and Hib vaccination and counsel on early presentation, as they are at risk of fulminant encapsulated-organism disease ^{[2]A1b[21]B2b}.

Prevention operates at two levels. At the population level, pediatric conjugate vaccination has reshaped adult epidemiology through herd protection, roughly halving incidence and shrinking the penicillin-resistant pneumococcal reservoir, though serotype replacement means surveillance and updated higher-valency vaccines (PCV15/20) remain necessary ^{[2]A1b[21]B2b}. At the individual level, recognizing and definitively repairing a CSF leak or treating chronic otomastoid disease is the most effective way to prevent the recurrent episodes that otherwise cluster in these patients ^{[9]B2b[11]B2b}. Chemoprophylaxis of close household and intimate contacts of meningococcal cases with rifampin , ciprofloxacin or ceftriaxone , combined with droplet precautions for the first 24 hours of the index patient's therapy, interrupts onward transmission ^[2]A1b.

Pearl: The caveat most often missed is omitting ampicillin for Listeria monocytogenes in the older, pregnant, or immunocompromised patient - a fatal gap because empiric ceftriaxone + vancomycin alone does not cover Listeria ^[18]D5[20]C4.